EXHIBIT 12.1 |
WAFERGEN BIO-SYSTEMS, INC.
STATEMENT OF COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
The following table sets forth our consolidated ratio of earnings to fixed charges for the periods indicated. |
Three | ||||||||||||||||||||||||
Months | ||||||||||||||||||||||||
Ended | ||||||||||||||||||||||||
March 31, | Year Ended December 31, | |||||||||||||||||||||||
2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||||||||||||||||||
(in thousands) | ||||||||||||||||||||||||
Earnings (losses): | ||||||||||||||||||||||||
Net loss before provision for income taxes | $ | (4,529 | ) | $ | (10,620 | ) | $ | (8,041 | ) | $ | (5,958 | ) | $ | (2,686 | ) | $ | (1,494 | ) | ||||||
Add: Fixed charges | 82 | 257 | 122 | 236 | 15 | 43 | ||||||||||||||||||
Less: Accretion on redeemable convertible preference shares in subsidiary | (66 | ) | (178 | ) | (38 | ) | — | — | — | |||||||||||||||
Adjusted loss | $ | (4,513 | ) | $ | (10,541 | ) | $ | (7,957 | ) | $ | (5,722 | ) | $ | (2,671 | ) | $ | (1,451 | ) | ||||||
Fixed charges: | ||||||||||||||||||||||||
Interest expense | $ | 1 | $ | 10 | $ | 15 | $ | 190 | $ | — | $ | 28 | ||||||||||||
Estimate of interest within rental expense | 15 | 69 | 69 | 46 | 15 | 15 | ||||||||||||||||||
Accretion on redeemable convertible preference shares in subsidiary | 66 | 178 | 38 | — | — | — | ||||||||||||||||||
Total fixed charges | $ | 82 | $ | 257 | $ | 122 | $ | 236 | $ | 15 | $ | 43 | ||||||||||||
Ratio of earnings to fixed charges(1) | — | — | — | — | — | — | ||||||||||||||||||
Deficiency of earnings to fixed charges | $ | 4,595 | $ | 10,798 | $ | 8,079 | $ | 5,958 | $ | 2,686 | $ | 1,494 |
(1) The Company has never generated earnings to cover fixed charges.